Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Implantable Cardiac Pacemaker Market by Type (Pacemaker, ICD, BI-V ICD), By Application (Bradycardia, Tachycardia, Heart Failure, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Implantable Cardiac Pacemaker Market by Type (Pacemaker, ICD, BI-V ICD), By Application (Bradycardia, Tachycardia, Heart Failure, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 169762 3300 Medical Devices & Consumables 377 232 Pages 4.6 (44)
                                          

The global implantable cardiac pacemaker market is expected to grow at a CAGR of 3.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of heart diseases and rising geriatric population. The implantable cardiac pacemaker market has been segmented on the basis of type, application, and region. The pacemaker segment accounted for the largest share in 2018 and is expected to continue its dominance throughout the forecast period due to its wide range of applications in various types of heart diseases such as bradycardia, tachycardia, and heart failure. The North American region dominated this market in 2018 with a share of over 40%. This can be attributed to high adoption rates for implantable cardiac pacemakers owing to increased awareness about their benefits among patients suffering from various types of heart diseases such as bradycardia, tachycardia, and heart failure. -The global implantable cardiac pacemaker market is expected to grow at a CAGR of 3.5% from 2017 to 2022. -The increasing prevalence of heart diseases and the growing geriatric population are the major factors driving the growth of this market. -Increasing awareness about implantable cardiac pacemakers among patients and physicians is also expected to fuel the growth of this market during the forecast period.

Industry Growth Insights published a new data on “Implantable Cardiac Pacemaker Market”. The research report is titled “Implantable Cardiac Pacemaker Market research by Types (Pacemaker, ICD, BI-V ICD), By Applications (Bradycardia, Tachycardia, Heart Failure, Other), By Players/Companies Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, IMZ, Pacetronix, Qinming Medical, Cardioelectronica, CCC”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Implantable Cardiac Pacemaker Market Research Report

By Type

Pacemaker, ICD, BI-V ICD

By Application

Bradycardia, Tachycardia, Heart Failure, Other

By Companies

Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, IMZ, Pacetronix, Qinming Medical, Cardioelectronica, CCC

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

232

Number of Tables & Figures

163

Customization Available

Yes, the report can be customized as per your need.


Global Implantable Cardiac Pacemaker Industry Outlook


Global Implantable Cardiac Pacemaker Market Report Segments:

The global Implantable Cardiac Pacemaker market is segmented on the basis of:

Types

Pacemaker, ICD, BI-V ICD

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Bradycardia, Tachycardia, Heart Failure, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Medtronic
  2. Abbott
  3. Boston Scientific
  4. Biotronik
  5. LivaNova (Sorin)
  6. Medico
  7. IMZ
  8. Pacetronix
  9. Qinming Medical
  10. Cardioelectronica
  11. CCC

Global Implantable Cardiac Pacemaker Market Overview


Highlights of The Implantable Cardiac Pacemaker Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Pacemaker
    2. ICD
    3. BI-V ICD
  1. By Application:

    1. Bradycardia
    2. Tachycardia
    3. Heart Failure
    4. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Implantable Cardiac Pacemaker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Implantable Cardiac Pacemaker Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


An implantable cardiac pacemaker is a small, battery-operated device that helps to maintain the rhythm of the heart. It is usually placed under the skin on one side of the chest. The pacemaker sends electrical impulses to help keep your heart beating normally.

Some of the key players operating in the implantable cardiac pacemaker market are Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, IMZ, Pacetronix, Qinming Medical, Cardioelectronica, CCC.

The implantable cardiac pacemaker market is expected to register a CAGR of 3.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Implantable Cardiac Pacemaker Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Implantable Cardiac Pacemaker Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Implantable Cardiac Pacemaker Market - Supply Chain
   4.5. Global Implantable Cardiac Pacemaker Market Forecast
      4.5.1. Implantable Cardiac Pacemaker Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Implantable Cardiac Pacemaker Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Implantable Cardiac Pacemaker Market Absolute $ Opportunity

5. Global Implantable Cardiac Pacemaker Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Implantable Cardiac Pacemaker Market Size and Volume Forecast by Type
      5.3.1. Pacemaker
      5.3.2. ICD
      5.3.3. BI-V ICD
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Implantable Cardiac Pacemaker Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Implantable Cardiac Pacemaker Market Size and Volume Forecast by Application
      6.3.1. Bradycardia
      6.3.2. Tachycardia
      6.3.3. Heart Failure
      6.3.4. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Implantable Cardiac Pacemaker Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Implantable Cardiac Pacemaker Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Implantable Cardiac Pacemaker Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Implantable Cardiac Pacemaker Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Implantable Cardiac Pacemaker Demand Share Forecast, 2019-2026

9. North America Implantable Cardiac Pacemaker Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Implantable Cardiac Pacemaker Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Implantable Cardiac Pacemaker Market Size and Volume Forecast by Application
      9.4.1. Bradycardia
      9.4.2. Tachycardia
      9.4.3. Heart Failure
      9.4.4. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Implantable Cardiac Pacemaker Market Size and Volume Forecast by Type
      9.7.1. Pacemaker
      9.7.2. ICD
      9.7.3. BI-V ICD
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Implantable Cardiac Pacemaker Demand Share Forecast, 2019-2026

10. Latin America Implantable Cardiac Pacemaker Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Implantable Cardiac Pacemaker Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Implantable Cardiac Pacemaker Market Size and Volume Forecast by Application
      10.4.1. Bradycardia
      10.4.2. Tachycardia
      10.4.3. Heart Failure
      10.4.4. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Implantable Cardiac Pacemaker Market Size and Volume Forecast by Type
      10.7.1. Pacemaker
      10.7.2. ICD
      10.7.3. BI-V ICD
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Implantable Cardiac Pacemaker Demand Share Forecast, 2019-2026

11. Europe Implantable Cardiac Pacemaker Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Implantable Cardiac Pacemaker Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Implantable Cardiac Pacemaker Market Size and Volume Forecast by Application
      11.4.1. Bradycardia
      11.4.2. Tachycardia
      11.4.3. Heart Failure
      11.4.4. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Implantable Cardiac Pacemaker Market Size and Volume Forecast by Type
      11.7.1. Pacemaker
      11.7.2. ICD
      11.7.3. BI-V CD
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Implantable Cardiac Pacemaker Demand Share, 2019-2026

12. Asia Pacific Implantable Cardiac Pacemaker Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Implantable Cardiac Pacemaker Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Implantable Cardiac Pacemaker Market Size and Volume Forecast by Application
      12.4.1. Bradycardia
      12.4.2. Tachycardia
      12.4.3. Heart Failure
      12.4.4. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Implantable Cardiac Pacemaker Market Size and Volume Forecast by Type
      12.7.1. Pacemaker
      12.7.2. ICD
      12.7.3. BI-V ICD
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Implantable Cardiac Pacemaker Demand Share, 2019-2026

13. Middle East & Africa Implantable Cardiac Pacemaker Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Implantable Cardiac Pacemaker Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Implantable Cardiac Pacemaker Market Size and Volume Forecast by Application
      13.4.1. Bradycardia
      13.4.2. Tachycardia
      13.4.3. Heart Failure
      13.4.4. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Implantable Cardiac Pacemaker Market Size and Volume Forecast by Type
      13.7.1. Pacemaker
      13.7.2. ICD
      13.7.3. BI-V ICD
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Implantable Cardiac Pacemaker Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Implantable Cardiac Pacemaker Market: Market Share Analysis
   14.2. Implantable Cardiac Pacemaker Distributors and Customers
   14.3. Implantable Cardiac Pacemaker Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Medtronic
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Abbott
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Boston Scientific
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Biotronik
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. LivaNova (Sorin)
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Medico
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. IMZ
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Pacetronix
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Qinming Medical
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Cardioelectronica
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. CCC
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us